Coronavirus drugs: Who's doing what, and when they might come
Pharmaceuticals and research labs across the world are racing to find vaccines and treatments for the new coronavirus, using a variety of different technologies.
Mar 16, 2020
1
433
Pharmaceuticals and research labs across the world are racing to find vaccines and treatments for the new coronavirus, using a variety of different technologies.
Mar 16, 2020
1
433
A drug candidate has been found in preclinical trials to stop tumor growth entirely, deliver more cancer-busting power than many commonly used chemotherapy drugs and do so with fewer toxic side effects and more ability to ...
Mar 16, 2020
0
210
A broad variety of autoimmune diseases involve the development of pathogenic immunoglobulin G (IgG) antibodies which can attack cells and tissues and form immune complexes with the antigen to which they are directed. Immune ...
Dec 18, 2019
0
50
In mouse models of Alzheimer's disease, the investigational drug candidates known as CMS121 and J147 improve memory and slow the degeneration of brain cells. Now, Salk researchers have shown how these compounds can also slow ...
Dec 10, 2019
1
516
According to the National Cancer Institute, approximately 38 percent of men and women will be diagnosed with cancer at some point in their lives. The current process for drug discovery is slow and sequential, and often involves ...
Oct 1, 2019
0
2
A bone cancer known as osteosarcoma is genetically similar in dogs and human children, according to the results of a study published today by Tufts University and the Translational Genomics Research Institute (TGen), an affiliate ...
Jul 19, 2019
0
4
A research team led by scientists from the Broad Institute has uncovered a novel group of chemical inhibitors that can kill the bacteria that causes tuberculosis (TB). Importantly, these chemical compounds take aim at a previously ...
Jun 20, 2019
0
0
University of California, Davis professor Bruce Hammock has spent a 50-year career studying insects. He probably wouldn't be the Ph.D. considered most likely to shake up the multibillion-dollar prescription painkiller market.
May 1, 2019
1
29
Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren't as effective as they could be. Oncologists haven't had the right tools to predict drug interactions, other than in costly ...
Feb 21, 2019
0
25
Researchers from Skoltech (Maxim Fedorov's group, CDISE) and the German Research Center for Environmental Health, Helmholtz Zentrum München (HMGU; Igor Tetko's group) have developed an enhanced drug candidate toxicity prediction ...
Jan 25, 2019
0
7